Showing results (161-170 of 193) with videos related to

Sort By:
Pageof 20
The Lancet. Oncology|December 20, 2014
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 studyMax S Topp, Nicola Gökbuget, Anthony S Stein, et al.
Leukemia & Lymphoma|January 19, 2018
Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survivalVicent Guillem, Marisa Calabuig, Salut Brunet, et al.
Scientific Reports|November 6, 2020
Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesisMarta Isidro-Hernández, Andrea Mayado, Ana Casado-García, et al.
Leukemia & Lymphoma|October 17, 2018
An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimensMarta Sobas, Pau Montesinos, Blanca Boluda, et al.
Leukemia Research|December 22, 2015
Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: Results of three prospective parallel trials from the PETHEMA groupJosep-Maria Ribera, Olga García, Albert Oriol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2014
Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trialJosep-Maria Ribera, Albert Oriol, Mireia Morgades, et al.
The New England Journal of Medicine|March 2, 2017
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic LeukemiaHagop Kantarjian, Anthony Stein, Nicola Gökbuget, et al.
Leukemia Research|March 26, 2018
Comparison of intensive, pediatric-inspired therapy with non-intensive therapy in older adults aged 55-65 years with Philadelphia chromosome-negative acute lymphoblastic leukemiaJosep-Maria Ribera, Olga García, Cristina Gil, et al.
Leukemia & Lymphoma|January 9, 2014
Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patientsBlanca Xicoy, Josep-Maria Ribera, Markus Müller, et al.
Bone Marrow Transplantation|December 4, 2025
Frequency and impact of somatic co-occurring mutations on post-transplant outcomes in acute myeloid leukemia: a multicenter registry analysis on behalf of the EBMT ALWPAli Bazarbachi, Jacques-Emmanuel Galimard, Iman Abou Dalle, et al.
Pageof 20